1. Home
  2. IOVA vs HLX Comparison

IOVA vs HLX Comparison

Compare IOVA & HLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • HLX
  • Stock Information
  • Founded
  • IOVA 2007
  • HLX 1979
  • Country
  • IOVA United States
  • HLX United States
  • Employees
  • IOVA N/A
  • HLX N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • HLX Oilfield Services/Equipment
  • Sector
  • IOVA Health Care
  • HLX Energy
  • Exchange
  • IOVA Nasdaq
  • HLX Nasdaq
  • Market Cap
  • IOVA 1.0B
  • HLX 931.9M
  • IPO Year
  • IOVA N/A
  • HLX 1997
  • Fundamental
  • Price
  • IOVA $1.75
  • HLX $6.54
  • Analyst Decision
  • IOVA Strong Buy
  • HLX Buy
  • Analyst Count
  • IOVA 9
  • HLX 3
  • Target Price
  • IOVA $15.50
  • HLX $12.50
  • AVG Volume (30 Days)
  • IOVA 13.9M
  • HLX 2.4M
  • Earning Date
  • IOVA 05-08-2025
  • HLX 04-23-2025
  • Dividend Yield
  • IOVA N/A
  • HLX N/A
  • EPS Growth
  • IOVA N/A
  • HLX N/A
  • EPS
  • IOVA N/A
  • HLX 0.55
  • Revenue
  • IOVA $212,679,000.00
  • HLX $1,340,413,000.00
  • Revenue This Year
  • IOVA $182.20
  • HLX $5.70
  • Revenue Next Year
  • IOVA $62.10
  • HLX $4.53
  • P/E Ratio
  • IOVA N/A
  • HLX $12.28
  • Revenue Growth
  • IOVA 11070.12
  • HLX 0.34
  • 52 Week Low
  • IOVA $2.70
  • HLX $5.66
  • 52 Week High
  • IOVA $13.60
  • HLX $13.05
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 23.78
  • HLX 45.59
  • Support Level
  • IOVA $3.02
  • HLX $5.96
  • Resistance Level
  • IOVA $3.31
  • HLX $6.84
  • Average True Range (ATR)
  • IOVA 0.24
  • HLX 0.33
  • MACD
  • IOVA -0.09
  • HLX 0.09
  • Stochastic Oscillator
  • IOVA 4.81
  • HLX 74.15

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.

Share on Social Networks: